Grove Bank & Trust’s ICU Medical ICUI Stock Holding History

Grove Bank & Trust’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11	Closed	-$1.31K	–	636
2023 Q3	$1.31K	Buy	+11	New	+$1.64K	﹤0.01%	675

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Grove Bank & Trust's ICUI Position: Q4 2023 in Review

Grove Bank & Trust sold out of ICU Medical (ICUI) in Q4 2023, closing a stake of 11 shares — an estimated $1.31K sold.

Grove Bank & Trust first reported a position in ICUI in Q3 2023 and held it in 1 quarter. The position peaked at $1.31K in Q3 2023. 241 funds tracked by Wall St. Rank hold ICUI as of Q4 2023.

Grove Bank & Trust reported no remaining ICU Medical position as of Q4 2023 after selling out during the quarter.
Grove Bank & Trust sold 11 ICU Medical shares in Q4 2023, an estimated $1.31K.
Grove Bank & Trust first reported a position in ICU Medical in Q3 2023 and held it in 1 quarter.
Grove Bank & Trust's ICU Medical position peaked at $1.31K in Q3 2023.
241 funds tracked by Wall St. Rank held ICU Medical as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.